ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-50 | 51-64

Results: 26-50/64

PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS

Authors: KATLAMA C DEWIT S ODOHERTY E VANGLABEKE M CLUMECK N PAYEN MC MATHIESEN L NIELSEN JO PEDERSEN C DUPONT B PIALOUX G JANBON F REYNES J GALLAIS H MARS ME JEANTILS V SCHNEIDER MC AVEROUS V DECAZES JM DOCOLECOMPTE T MODAI J MOLINA JM BLANC A DELFRAISSY JF GUILLEVIN L JARROUSSE B SEHOUANE R TROGOFF B ARMENGAUD M MARCHOU B MEURISSE JJ GENTILINI M GUICHARD A ROGEAUX O LIVROZET JM TOURAINE JL SERENI D ROUSSEAU F PESCE A COULAUD JP DETRUCHIS P FEGUEUX S MASLO C MATHERON S RAFFI F BASSETTI D CANESSA A DELBONO V DELEO P TERRAGNA A ANTINORI A DAMIANO F ORTONA L PALLAVICINI F TAMBURRINI E ANGARANO G CARBONARA S PASTORE G PORTEGIES P REISS P COSTA J MACHADO J MALTEZ F MORGADO A PROENCA R ANTUNES F CARVALHO C DOROANA M DUARTE N ARAUJO C CHAMPALIMAUD JL COSTA J MANSINHO K SEIXAS J LACRUZ J LOPEZALDEGUER J GATELL JM GUELAR A MALLOLAS J MIRO JM ZAMORA L CLOTET B JOU A RAVENTOS A ROMEU J SIRERA G BOLAO F CASANOVA A GUDIOL F PODZAMCZER D GAZAPO E GONZALEZLAHOZ JM BLANCO LM MORENO V POLO R MARTINEZ MC SANZ J VERDEJO J COSIN J MIRALLES P MORENO S PEREZTASCON O HIRSCHEL B PERRIER A RASSAERT C SOMMEREIJNS B UBRICH V BERLUREAU P DORMONT J LEVY JP MEUNIER F MIGNOLET F VANGLABEKE M VANPOTTELSBERGE C

Citation: C. Katlama et al., PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(2), 1996, pp. 268-275

ANTIBIOTIC SUSCEPTIBILITY OF GRAM-NEGATIV E BACTERIA ISOLATED FROM SEVERE INFECTIONS IN 1992 - RESULTS OF A FRENCH MULTICENTER STUDY

Authors: KOECK JL CAVALLO JD FABRE R MEYRAN M ROUE R AUBERTIN J LACUT J BEBEAR C DUPON M MORLAT P GARRE M CHASTEL C GARO B TANDE D REY M BEYTOUT J SIROT J LAURICHESSE H MARTIN D PORTIER H KAZMIERZACK A KISTERMAN JP DUEZ JM MICOUD M STAHL JP LENOC P BOSSERAY A BEAUCAIRE G MOUTON Y BEUSCART C LEROY O CAILLAUX M PEYRAMOND D TIGAUD S JAMBON F BERTHELEMY C DESPAUX E CANTON P GERARD A BURDIN JC MAY T LION D RAFFI F BLANLOEIL Y CAILLON J DELLAMONICA P LEFEBVRE JC BERNARD E ELBAZE P DEBORD T BECQGIRAUDON B ROBLOT F GRIGNON B REMY G CHIPPAUX C JAUSSAUD R VERNET V CARTIER P AVRIL JL BEURRIER P HUMBERT G LEMELAND JF CARON F CRISTMANN D MONTEIL H CHOUTET P BESNIER JM

Citation: Jl. Koeck et al., ANTIBIOTIC SUSCEPTIBILITY OF GRAM-NEGATIV E BACTERIA ISOLATED FROM SEVERE INFECTIONS IN 1992 - RESULTS OF A FRENCH MULTICENTER STUDY, La Presse medicale, 25(30), 1996, pp. 1363-1366

RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DEFINITION OF INDICATIONS FOR PRIMARY PROPHYLAXIS - PRPOSALS OF THE PE-TOXOPLASMOSE-ET-AUTRES-INFECTIONS-A-PROTOZOAIRE

Authors: LEPORT C AMBROISETHOMAS P BAZIN C CHENE G DEROUIN F KATLAMA C MAYAUD C PELLOUX H RAFFI F VILDE JL

Citation: C. Leport et al., RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DEFINITION OF INDICATIONS FOR PRIMARY PROPHYLAXIS - PRPOSALS OF THE PE-TOXOPLASMOSE-ET-AUTRES-INFECTIONS-A-PROTOZOAIRE, La Presse medicale, 25(11), 1996, pp. 519-520

EFFICACY AND TOLERANCE OF THE JOSAMYCIN 5 OR 10 DAYS VERSUS AZITHROMYCIN 5 DAYS IN THE TREATMENT OF ACUTE BRONCHITIS IN ADULTS

Authors: BRAMBILLA C RAFFI F LESCALE O SCHEIMBERG A ARCHIMBAUD A BOGETTO D BOUCHET J CANONICA R CARNIAUX F CATEL M CLAUSTRE P CLIER O DUFOUR J ECOCHARDCIRICA N ELSAWY A FAVRE JC FONTI P GALAVIELLE C GIRARDIER G GSTALDER M GUICHARD G KESPERN A LACAZE R LACHENAL G LEBROZEC Y LECLERCQ A LEVY P MUNOZ M PARMENTIER D PISON D PONARD J SALEMBIER A SCHAEGIS D SELLES G SONNIER D VANBELLEGEM D YALICHEFF C BLANCHE M BOYE A CASTELLANI J CHAUVEL P COZIC JA DAHAN G DELELISFANIEN A DOLLE J EUMONT D FEUVRIER G FORMAGNE L FORTIS A FOURAGE JF GAUDIN G GODDE P GRACOVETSKY A HAMON P LACROIX PV LEBERRE P LEQUEUX Y MANSAT G MOREZ Y MUSSAT P PERIMONY C PERROT P PIQUET P SAVARY N SIMON JJ THUAL Y BONNEFOND JL SAULIERE M COMPAN D

Citation: C. Brambilla et al., EFFICACY AND TOLERANCE OF THE JOSAMYCIN 5 OR 10 DAYS VERSUS AZITHROMYCIN 5 DAYS IN THE TREATMENT OF ACUTE BRONCHITIS IN ADULTS, Medecine et maladies infectieuses, 26(8-9), 1996, pp. 781-786

AZITHROMYCIN FOR THE TREATMENT OF COMMUNI TY-ACQUIRED BRONCHITIS - A LARGE, OPEN, MULTICENTER, EFFICACY-TOLERANCE TRIAL

Authors: RAFFI F

Citation: F. Raffi, AZITHROMYCIN FOR THE TREATMENT OF COMMUNI TY-ACQUIRED BRONCHITIS - A LARGE, OPEN, MULTICENTER, EFFICACY-TOLERANCE TRIAL, Medecine et maladies infectieuses, 26(12), 1996, pp. 1183-1187

AZITHROMYCIN FOR THE TREATMENT OF ACUTE P HARYNGITIS IN ADULTS - A LARGE, OPEN MULTICENTER, EFFICACY-TOLERANCE TRIAL

Authors: RAFFI F

Citation: F. Raffi, AZITHROMYCIN FOR THE TREATMENT OF ACUTE P HARYNGITIS IN ADULTS - A LARGE, OPEN MULTICENTER, EFFICACY-TOLERANCE TRIAL, Medecine et maladies infectieuses, 26(10), 1996, pp. 855-857

MUST ALL PHARYNGITIS BE TREATED BY ANTIBI OTICS

Authors: RAFFI F

Citation: F. Raffi, MUST ALL PHARYNGITIS BE TREATED BY ANTIBI OTICS, Medecine et maladies infectieuses, 26(10), 1996, pp. 863-864

PROGNOSIS FACTORS AND COMPLICATIONS OF PN EUMOCOCCAL MENINGITIS - RESULTS OF A MULTICENTER STUDY

Authors: STAHL JP GESLIN P BRION JP STRUILLOU L RAFFI F PATEY O FAUCONNIER J

Citation: Jp. Stahl et al., PROGNOSIS FACTORS AND COMPLICATIONS OF PN EUMOCOCCAL MENINGITIS - RESULTS OF A MULTICENTER STUDY, Medecine et maladies infectieuses, 26, 1996, pp. 989-994

AMPHOTERICIN-B IN A LIPID EMULSION FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN AIDS PATIENTS

Authors: JOLY V GEOFFRAY C REYNES J GOUJARD C MECHALI D MASLO C RAFFI F YENI P

Citation: V. Joly et al., AMPHOTERICIN-B IN A LIPID EMULSION FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN AIDS PATIENTS, Journal of antimicrobial chemotherapy, 38(1), 1996, pp. 117-126

COMPARATIVE EFFICACY OF SPARFLOXACIN IN COMPARISON WITH AMOXICILLIN PLUS OFLOXACIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA

Authors: PORTIER H MAY T PROUST A TOLSTUCHOW N MUIR JF BALMES P",PAGANIN,"CARLES P BLANCHON F ROCHEMAURE J TONNEL AB DUMONT P WALLAERT C RAGNAUD JM BECQGIRAUDON B NOUVET G WEITZENBLUM E LENG B GAILLAT J DEFOUILLOY C ARNAUD A HERER B MIECH G MODAI J CREPIN JL BERNARD P CORDIER JF BART F CLAVIER J STAHL JP POLU JM LACROIX S JEANNIN L BENOIT JP BALGARIES JL BARBIEUX H BEYTOUT J PARIENTE R PATEY O RAFFI F TUCHAIS E SERGEANT YH CHOUTET P CAILLAUX D

Citation: H. Portier et al., COMPARATIVE EFFICACY OF SPARFLOXACIN IN COMPARISON WITH AMOXICILLIN PLUS OFLOXACIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA, Journal of antimicrobial chemotherapy, 37, 1996, pp. 83-91

ATOVAQUONE AS LONG-TERM SUPPRESSIVE THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS AND MULTIPLE-DRUG INTOLERANCE

Authors: KATLAMA C MOUTHON B GOURDON D LAPIERRE D ROUSSEAU F ALLEGRE T DROBACHEFF C MONLUN E MALAMUD P SALLES B ROGEZ JF GRANETBRUNELLO P COTTE L CHAUMENTIN G LECLERC V TOLLINCHI F MOREAU J DHIVER C DURAND JM XERIDAT B RAVAUX I REYNES J WINTER C RABAUD C RAFFI F FUZIBERT JG VINTI H GOUGEARD C PERICHON I GILQUIN J CHAPUIS L JEANTILS V GREGOIRE V CHAPUT S DETRUCHIS P PICARD O CROS H BORSALEBAS F LAFEUILLADE A AVEROUS S BOUREZ JM PRAZUCK T

Citation: C. Katlama et al., ATOVAQUONE AS LONG-TERM SUPPRESSIVE THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS AND MULTIPLE-DRUG INTOLERANCE, AIDS, 10(10), 1996, pp. 1107-1112

REACTIVE HEMOPHAGOCYTIC SYNDROME IN AIDS

Authors: TIAB M LACROIX FM HAMIDOU M GAILLARD F RAFFI F

Citation: M. Tiab et al., REACTIVE HEMOPHAGOCYTIC SYNDROME IN AIDS, AIDS, 10(1), 1996, pp. 108-111

A NEUROBORRELIOSIS PSYCHIATRIC FORM - ONE OBSERVATION

Authors: GUEGLIO B RAFFI F MARJOLET M

Citation: B. Gueglio et al., A NEUROBORRELIOSIS PSYCHIATRIC FORM - ONE OBSERVATION, La Revue de medecine interne, 17(7), 1996, pp. 599-599

THROMBOTIC MICROANGIOPATHY IN HIV-INFECTI ON - REPORT OF 4 CASES

Authors: NININ E MERRIEN D HAMIDOU M TESTA A MILPIED B RAFFI F

Citation: E. Ninin et al., THROMBOTIC MICROANGIOPATHY IN HIV-INFECTI ON - REPORT OF 4 CASES, La Revue de medecine interne, 17(3), 1996, pp. 238-242

POLYMORPHONUCLEAR NEUTROPHILS MENINGITIS REVEALING MYCOPLASMA-PNEUMONIAE INFECTION

Authors: AGARD C HAMIDOU M GIRES C GROLLEAU JY RAFFI F

Citation: C. Agard et al., POLYMORPHONUCLEAR NEUTROPHILS MENINGITIS REVEALING MYCOPLASMA-PNEUMONIAE INFECTION, La Revue de medecine interne, 17(12), 1996, pp. 1043-1044

LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA (VOL 172, PG 656, 1995)

Authors: SALMONCERON C FONTBONNE A SABA J MAY T RAFFI F CHIDIAC C PATEY O ABOULKER JP SCHWARTZ D VILDE JL

Citation: C. Salmonceron et al., LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA (VOL 172, PG 656, 1995), The Journal of infectious diseases, 173(1), 1996, pp. 277-277

RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N HIV-INFECTED PATIENTS - DEFINING INDICATIONS FOR PRIMARY PROPHYLAXIS

Authors: LEPORT C AMBROISETHOMAS P BAZIN C CHENE G DEROUIN F KATLAMA C MAYAUD C PELLOUX H RAFFI F VILDE JL

Citation: C. Leport et al., RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N HIV-INFECTED PATIENTS - DEFINING INDICATIONS FOR PRIMARY PROPHYLAXIS, Annales de medecine interne, 147(5), 1996, pp. 331-332

REACTIVE HEMOPHAGOCYTIC SYNDROME - A SERI ES OF 23 CASES

Authors: TIAB M MECHINAUD F HAMIDOU M GAILLARD F RAFFI F HAROUSSEAU JL

Citation: M. Tiab et al., REACTIVE HEMOPHAGOCYTIC SYNDROME - A SERI ES OF 23 CASES, Annales de medecine interne, 147(3), 1996, pp. 138-144

METASTATIC BACTERIAL ENDOPHTHALMITIS, A U NUSUAL INFECTIOUS-DISEASE WITH A VERY POOR-PROGNOSIS

Authors: MAGADURJOLY G RAFFI F BOUCHUT P CHEVALET P MERRIEN D STRUILLOU L BARRIER JH

Citation: G. Magadurjoly et al., METASTATIC BACTERIAL ENDOPHTHALMITIS, A U NUSUAL INFECTIOUS-DISEASE WITH A VERY POOR-PROGNOSIS, Annales de medecine interne, 147(3), 1996, pp. 212-217

USE OF AN ITRACONAZOLE ALLOPURINOL COMBINATION FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN A PATIENT WITH AIDS/

Authors: RAFFI F MERRIEN D LEPAPE P RELIQUET V

Citation: F. Raffi et al., USE OF AN ITRACONAZOLE ALLOPURINOL COMBINATION FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN A PATIENT WITH AIDS/, Clinical infectious diseases, 21(5), 1995, pp. 1338-1339

BREAKTHROUGH CEREBRAL TOXOPLASMOSIS IN PATIENTS WITH AIDS WHO ARE BEING TREATED WITH CLARITHROMYCIN

Authors: RAFFI F STRUILLOU L NININ E RELIQUET V BILLAUD E MILPIED B

Citation: F. Raffi et al., BREAKTHROUGH CEREBRAL TOXOPLASMOSIS IN PATIENTS WITH AIDS WHO ARE BEING TREATED WITH CLARITHROMYCIN, Clinical infectious diseases, 20(4), 1995, pp. 1076-1077

CLINICAL AND BACTERIOLOGICAL ASPECTS OF N OCARDIAL INFECTIONS - A SERIES OF 9 CASES

Authors: BANISADR F HAMIDOU M RAFFI F CHAMOUX C CAILLON J FRELAND C

Citation: F. Banisadr et al., CLINICAL AND BACTERIOLOGICAL ASPECTS OF N OCARDIAL INFECTIONS - A SERIES OF 9 CASES, La Presse medicale, 24(23), 1995, pp. 1062-1066

ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/

Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J

Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035

COLORIMETRIC MICROTITER PLATE HYBRIDIZATION ASSAY USING MONOCLONAL-ANTIBODY FOR DETECTION OF AN AMPLIFIED HUMAN-IMMUNODEFICIENCY-VIRUS TARGET

Authors: FERREAUBINEAU V IMBERTMARCILLE BM RAFFI F BESSE B LOIRAT R BILLAUDEL S

Citation: V. Ferreaubineau et al., COLORIMETRIC MICROTITER PLATE HYBRIDIZATION ASSAY USING MONOCLONAL-ANTIBODY FOR DETECTION OF AN AMPLIFIED HUMAN-IMMUNODEFICIENCY-VIRUS TARGET, Journal of virological methods, 55(1), 1995, pp. 145-151

A CONTROLLED TRIAL OF ZIDOVUDINE IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

Authors: KINLOCHDELOES S HIRSCHEL BJ HOEN B COOPER DA TINDALL B CARR A SAURAT JH CLUMECK N LAZZARIN A MATHIESEN L RAFFI F ANTUNES F VONOVERBECK J LUTHY R GLAUSER M HAWKINS D BAUMBERGER C YERLY S PERNEGER TV PERRIN L

Citation: S. Kinlochdeloes et al., A CONTROLLED TRIAL OF ZIDOVUDINE IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 333(7), 1995, pp. 408-413

Risultati: 1-25 | 26-50 | 51-64